These studies confirm that EVs not only deliver genetic material but also support complex cell fate changes, suggesting potential applications for EV-mediated gene delivery in AD research, where tau pathology modeling requires stable expression of tau-related genes in neuronal cells. The gene discussed is MAPT; the disease is Alzheimer disease.